KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
about
Colorectal Cancer Biomarkers: Where Are We Now?Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer.Radioembolization treatment for liver metastases.
P2860
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@ast
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en-gb
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@nl
type
label
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@ast
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en-gb
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@nl
prefLabel
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@ast
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en-gb
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@nl
P2093
P2860
P356
P1433
P1476
KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic
@en
P2093
Grace Wang
Robin K Kelley
P2860
P304
P356
10.1371/CURRENTS.RRN1175
P407
P577
2010-01-01T00:00:00Z